BigiX Pharma

Asti, Italy Founded: 2017 • Age: 9 yrs Acquired By Biosynex
Manufacturer of half cylinder cushion, antibacterial wedge sanitizers

About BigiX Pharma

BigiX Pharma is a Healthcare company based in Asti (Italy) founded in 2017, and was acquired by Biosynex in September 2022. Manufacturer of half cylinder cushion, antibacterial wedge sanitizers. Its chief executive, as recorded, is Vittorio Pesato. Its focus areas include Traditional Medical Devices.

Company details

BigiX Pharma, based in Asti, focuses on providing healthcare solutions, and traditional medical devices. Manufacturer of half cylinder cushion, antibacterial wedge sanitizers. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Asti, Italy
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website bigix.it
  • Acquired by Biosynex (Sep 2022)
Key Metrics

Investors in BigiX Pharma

BigiX Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Biosynex.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Professional rapid diagnostic tests for diseases are manufactured by Biosynex.
2005biosynex.comStrasbourg, France
Premium access

Investor details for BigiX Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BigiX Pharma

1 people are tracked at BigiX Pharma (1 in leadership).

NameRoleGroup
Vittorio Pesato
CEOLeadership
Premium access

Complete people profiles for BigiX Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BigiX Pharma

2 dated milestones of BigiX Pharma across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded BigiX Pharma is founded.
  2. Exit Acquired by Biosynex.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BigiX Pharma

BigiX Pharma was founded in 2017.

BigiX Pharma is headquartered in Asti, Italy. It is registered at Asti, Piemonte, Italy.

Vittorio Pesato is the CEO of BigiX Pharma, as recorded in our data.

BigiX Pharma, based in Asti, focuses on providing healthcare solutions, and traditional medical devices. Manufacturer of half cylinder cushion, antibacterial wedge sanitizers. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

BigiX Pharma has 1 investor. Key investors include Biosynex.

Yes. BigiX Pharma was acquired by Biosynex in September 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available